Emily K. Colvin
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 16
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
- Cancer-related molecular mechanisms research 4
- Surgery top 5%
- Pancreatitis Pathology and Treatment 8
- Pancreatic function and diabetes 4
- Genetics top 10%
-
- Cancer Research and Treatments 5
-
- Neuroendocrine Tumor Research Advances 4
-
- RNA modifications and cancer 3
- Co-authors
- Christopher J. ScarlettViive M. HowellAndrew V. BiankinAnthony J. GillDavid K. ChangJames G. KenchAmber L. JohnsNeil D. Merrett
- Cited by
- OncologyCancer ResearchSurgery
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Emily K. Colvin
39 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 99
- Oncology 883
- Cancer Research 322
- Surgery 621
- Immunology 214
- Genetics 107
Countries citing papers authored by Emily K. Colvin
This map shows the geographic impact of Emily K. Colvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily K. Colvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily K. Colvin more than expected).
Fields of papers citing papers by Emily K. Colvin
This network shows the impact of papers produced by Emily K. Colvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily K. Colvin. The network helps show where Emily K. Colvin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily K. Colvin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 24 | |
| 3 | 2023 | 2 | |
| 4 | 2019 | 2 | |
| 5 | 2018 | 46 | |
| 6 | 2018 | 28 | |
| 7 | 2016 | 9 | |
| 8 | 2015 | 100 | |
| 9 | 2015 | 1 | |
| 10 | 2015 | 14 | |
| 11 | 2014 | 3 | |
| 12 | 2014 | 21 | |
| 13 | 2014 | 147 | |
| 14 | 2013 | 61 | |
| 15 | 2013 | 52 | |
| 16 | 2011 | 298 | |
| 17 | 2011 | 20 | |
| 18 | 2009 | 6 | |
| 19 | 2008 | 18 | |
| 20 | 2006 | 6 |
About Emily K. Colvin
Emily K. Colvin is a scholar working on Oncology, Cancer Research and Biotechnology, having authored 40 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Pancreatitis Pathology and Treatment (8 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Research and Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Pancreatic function and diabetes (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Oncology (883 citations), Cancer Research (322 citations) and Surgery (621 citations). Emily K. Colvin has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Christopher J. Scarlett, Viive M. Howell, Andrew V. Biankin, Anthony J. Gill, David K. Chang, James G. Kench, Amber L. Johns, Neil D. Merrett, Robert L. Sutherland and Jaswinder S. Samra. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.